Athersys
ATHX
#10736
Rank
NZ$1.39 M
Marketcap
NZ$0.02254
Share price
-33.50%
Change (1 day)
-98.91%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -NZ$67.38 Million

According to Athersys's latest financial reports the company's current earnings are NZ$0.08 Million. In 2022 the company made an earning of -NZ$0.13 Billion, an increase over its 2021 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$67.38 Million-47.59%
2022 -NZ$0.13 Billion-11.54%
2021 -NZ$0.15 Billion11.14%
2020 -NZ$0.14 Billion72.2%
2019 -NZ$75.94 Million77.29%
2018 -NZ$42.84 Million-22.91%
2017 -NZ$55.57 Million111.89%
2016 -NZ$26.23 Million-8.52%
2015 -NZ$28.67 Million-40.81%
2014 -NZ$48.44 Million18.62%
2013 -NZ$40.83 Million
2011 -NZ$23.01 Million19.71%
2010 -NZ$19.22 Million-26.28%
2009 -NZ$26.07 Million-18.21%
2008 -NZ$31.88 Million-8.28%
2007 -NZ$34.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.36 B-62,307.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.68 B-25,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.16 B-21,859.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.78 B-18,438.39%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$21.95 B-31,592.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.02 B-23,080.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$0.27 B-499.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.2 Billion 7,351.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-NZ$1.05 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA